BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND ERC1, ELKS, 23085, ENSG00000082805, MGC12974, RAB6IP2, KIAA1081, Cast2, Q8IUD2, KIAA108
7 results:

  • 1. Successful Crizotinib-targeted Therapy of Pediatric Unresectable erc1::ALK Fusion Sarcoma.
    Wood ML; Fanburg-Smith JC; Brian JM; White JC; Powell JL; Freiberg AS
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):e184-e187. PubMed ID: 38099690
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Frequent EGFR exon 20 insertion in the so-called peripheral-type squamous cell neoplasm of uncertain malignant potential: a variant of bronchiolar adenoma or under-recognised entity?
    Zheng Q; Hou L; Shang G; Qi X; Zhang M; Jin Y; Wang Y; Xue Q; Wu C; Li Y
    Histopathology; 2023 Aug; 83(2):178-192. PubMed ID: 36864007
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Identification of RET fusions in a Chinese multicancer retrospective analysis by next-generation sequencing.
    Shi M; Wang W; Zhang J; Li B; Lv D; Wang D; Wang S; Cheng D; Ma T
    Cancer Sci; 2022 Jan; 113(1):308-318. PubMed ID: 34710947
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Molecular and clinical analysis of Chinese patients with anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.
    Zhou X; Shou J; Sheng J; Xu C; Ren S; Cai X; Chu Q; Wang W; Zhen Q; Zhou Y; Li W; Pan H; Li H; Sun T; Cheng H; Wang H; Lou F; Rao C; Cao S; Pan H; Fang Y
    Cancer Sci; 2019 Oct; 110(10):3382-3390. PubMed ID: 31444835
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Analysis of the Genomic Landscape in ALK+ NSCLC Patients Identifies Novel Aberrations Associated with Clinical Outcomes.
    Couëtoux du Tertre M; Marques M; Tremblay L; Bouchard N; Diaconescu R; Blais N; Couture C; Pelsser V; Wang H; Higenell V; Izzi L; Gambaro K; Hoffert C; Srivastava A; Spatz A; Rousseau C; McNamara S; Cohen V; Batist G; Agulnik J
    Mol Cancer Ther; 2019 Sep; 18(9):1628-1636. PubMed ID: 31243098
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Identification of nicotinamide aminonaphthyridine compounds as potent RET kinase inhibitors and antitumor activities against RET rearranged lung adenocarcinoma.
    Wang M; Naganna N; Sintim HO
    Bioorg Chem; 2019 Sep; 90():103052. PubMed ID: 31226468
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Antibodies to active zone protein erc1 in Lambert-Eaton myasthenic syndrome.
    Huijbers MG; Lipka AF; Potman M; Hensbergen PJ; Titulaer MJ; Niks EH; van der Maarel SM; Klooster R; Verschuuren JJ
    Hum Immunol; 2013 Jul; 74(7):849-51. PubMed ID: 23583364
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.